Frequently Asked Questions
The market is segmented based on , By Treatment (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Arterial Thromboembolism (AT), Stroke, and Others), Therapeutic Class (Novel Oral Anticoagulants (NOAC), Heparin, Vitamin K Antagonists, and Others), Drug Type (Bivalirudin, Dabigatran, Edoxaban, Betrixaban, Rivaroxaban, Apixaban, Enoxaparin, Dalteparin, and Others), Route of Administration (Oral and Parenteral), Therapeutic Area (Cardiovascular, Respiratory, Oncology, Nephrology, CNS, and Others), Procedure (Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, and Heart Valve Replacement), Type (Generics and Branded), End User (Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Industry Trends and Forecast to 2031.
.
The Global Anticoagulation Therapy Market size was valued at USD 29.97 USD Billion in 2023.
The Global Anticoagulation Therapy Market is projected to grow at a CAGR of 8.39% during the forecast period of 2024 to 2031.
The major players operating in the market include Hikma Pharmaceuticals PLC (Jordan), Mylan N.V. (Netherlands), Teva Pharmaceutical Industries Ltd. (Israel, Novartis AG (Switzerland), Eisai Co., Ltd. (Japan), Pfizer Inc. (U.S.), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Fresenius Kabi AG (Germany), Aspen Holdings (South Africa), Shanghai Fosun Pharmaceutical(Group)Co., Ltd. (China), Cipla Inc. (India), Johnson & Johnson Services, Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim International GmbH (Germany), Bristol-Myers Squibb Company (U.S.), DAIICHI SANKYO COMPANY, LIMITED (Japan), Eagle Pharmaceuticals, Inc. (U.S.), Endo International plc (Ireland), Mitsubishi Tanabe Pharma Corporation (Japan), Portola Pharmaceuticals, Inc. (U.S.), and Taro Pharmaceutical Industries Ltd. (Israel).
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
